IMVT

Immunovant Inc

NASDAQ · Biotechnology

$27.05

+2.99 (+12.43%)

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

Analyst Consensus

Buy

23 analysts

Buy 17 74%

Hold 6 26%

Sell 0 0%

Price Target

Analyst Price Target +125.3% upside

Low Target $43.15

Average Target $60.94

High Target $94.48

Current Price $27.05

Current
$27.05

Target
$60.94

$43.15 $60.94 avg $94.48